Vnitr Lek 2011, 57(9):786-790

Thyreopathy in primary care

P. Vlček
Klinika nukleární medicíny a endokrinologie 2. lékařské fakulty UK a FN Motol Praha, přednosta doc. MUDr. Petr Vlček, CSc.

Thyroid gland disorders, as the core of all endocrinopathies, affect 5-7% of the population of the Czech Republic, with women being affected 6-8 times more often than men. Clinically, thyreopathies are divided into hormonal production disorders and morphology disorders. Thyroid hormones fT3, fT4 and TSH serum levels determine the diagnosis of a thyroid gland disorder. Primary hypothyreosis is characterized by reduced fT4 and increased TSH. Low T3 syndrome is a protective reaction of the organism and is associated with conversion of T4 into hormonally inactive triiodothyronine (rT3). Primary hyperthyreosis is characterized by higher fT4 and low TSH levels. Acute thyreoiditis: Inflammatory signs and normal thyroid function, anti-TPO as well as anti-TG are not elevated. Subacute thyreoiditis is manifested as an inflammation, normal anti-TPO and anti-TG, sometimes also hyperthyreosis. Chronic thyreoiditis, Hashimoto's struma is among the most frequent causes of hypothyreosis in the Czech Republic and it is diagnosed through high anti-TPO and anti-TG levels and higher TSH. Thyreoidal adenomas and carcinomas are clinically usually euthyroid. Determination of tumour markers - thyreoglobulines in papillary and follicular carcinomas and calcitonin in medullar carcinoma that requires genetic assessment (determination of germinal mutations, usually with PCR) - is essential.

Keywords: thyroid gland; hypothyreosis; hyperthyreosis; thyroxin; TSH; fT4; inflammation; tumours

Received: April 28, 2011; Published: September 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vlček P. Thyreopathy in primary care. Vnitr Lek. 2011;57(9):786-790.
Download citation

References

  1. Límanová Z, Němec J, Zamrazil V. Nemoci štítné žlázy. 1. vyd. Praha: Galén 1995.
  2. Stárka L, Zamrazil V et al. Základy klinické endokrinologie. 2. vyd. Praha: Maxdorf 2005.
  3. McDermott MT. In the clinic. Hypothyroidism. Ann Intern Med 2009; 151: ITC61. Go to original source... Go to PubMed...
  4. Zamrazil V. Subklinické tyreopatie. Intern Med Pro Prax 2004; 5: 295-299.
  5. Vlček P, Neumann J. Karcinom štítné žlázy, pooperační sledování nemocných. 1. vyd. Praha: Maxdorf 2002.
  6. Dvořáková S, Václavíková E, Sýkorová V et al. New multiple somatic mutations in the RET proto-oncogene associated with sporadic medullary thyroid carcinoma. Thyroid 2006; 16: 311-316. Go to original source... Go to PubMed...
  7. Vlček P. Nádory štítné žlázy. In: Límanová Z. Štítná žláza. Edice: Trendy soudobé endokrinologie 2. Praha: Galén 2006: 299-314.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.